scholarly journals Clinical management of common cold in the perspective of primary care

2018 ◽  
Vol 2 (3) ◽  
Author(s):  
Hiroshi Bando
2005 ◽  
Vol 19 (5) ◽  
pp. 285-303 ◽  
Author(s):  
Sander JO Veldhuyzen van Zanten ◽  
Marc Bradette ◽  
Naoki Chiba ◽  
David Armstrong ◽  
Alan Barkun ◽  
...  

The present paper is an update to and extension of the previous systematic review on the primary care management of patients with uninvestigated dyspepsia (UD). The original publication of the clinical management tool focused on the initial four- to eight-week assessment of UD. This update is based on new data from systematic reviews and clinical trials relevant to UD. There is now direct clinical evidence supporting a test-and-treat approach in patients with nondominant heartburn dyspepsia symptoms, and head-to-head comparisons show that use of a proton pump inhibitor is superior to the use of H2-receptor antagonists (H2RAs) in the initial treatment of Helicobacter pylori-negative dyspepsia patients. Cisapride is no longer available as a treatment option and evidence for other prokinetic agents is lacking. In patients with long-standing heartburn-dominant (ie, gastroesophageal reflux disease) and nonheartburn-dominant dyspepsia, a once-in-a-lifetime endoscopy is recommended. Endoscopy should also be considered in patients with new-onset dyspepsia that develops after the age of 50 years. Conventional nonsteroidal anti-inflammatory drugs, acetylsalicylic acid and cyclooxygenase-2-selective inhibitors can all cause dyspepsia. If their use cannot be discontinued, cotherapy with either a proton pump inhibitor, misoprostol or high-dose H2RAs is recommended, although the evidence is based on ulcer data and not dyspepsia data. In patients with nonheartburn-dominant dyspepsia, noninvasive testing for H pylori should be performed and treatment given if positive. When starting nonsteroidal anti-inflammatory drugs for a prolonged course, testing and treatment with H2RAs are advised if patients have a history of previous ulcers or ulcer bleeding.


1999 ◽  
Vol 34 (1) ◽  
pp. 241-245 ◽  
Author(s):  
Guy R Randolph ◽  
Donald J Hagler ◽  
Bijoy K Khandheria ◽  
Eric R Lunn ◽  
Walter J Cook ◽  
...  

2017 ◽  
Vol 7 (3) ◽  
pp. 236-243 ◽  
Author(s):  
Reyan Ghany ◽  
Leonardo Tamariz ◽  
Gordon Chen ◽  
Alina Ghany ◽  
Emancia Forbes ◽  
...  

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Johannes Just ◽  
Marie-Therese Puth ◽  
Felix Regenold ◽  
Klaus Weckbecker ◽  
Markus Bleckwenn

Abstract Background Combating the COVID-19 pandemic is a major challenge for health systems, citizens and policy makers worldwide. Early detection of affected patients within the large and heterogeneous group of patients with common cold symptoms is an important element of this effort, but often hindered by limited testing resources, false-negative test results and the lack of pathognomonic symptoms in COVID-19. Therefore, we aimed to identify anamnestic items with an increased/decreased odds ratio for a positive SARS-CoV-2 PCR (CovPCR) result in a primary care setting. Methods We performed a multi-center cross-sectional cohort study on predictive clinical characteristics for a positive CovPCR over a period of 4 weeks in primary care patients in Germany. Results In total, 374 patients in 14 primary care centers received CovPCR and were included in this analysis. The median age was 44.0 (IQR: 31.0–59.0) and a fraction of 10.7% (n = 40) tested positive for COVID-19. Patients who reported anosmia had a higher odds ratio (OR: 4.54; 95%-CI: 1.51–13.67) for a positive test result while patients with a sore throat had a lower OR (OR: 0.33; 95%-CI: 0.11–0.97). Furthermore, patients who had a first grade contact with an infected persons and showed symptoms themselves also had an increased OR for positive testing (OR: 5.16; 95% CI: 1.72–15.51). This correlation was also present when they themselves were still asymptomatic (OR: 12.55; 95% CI: 3.97–39.67). Conclusions Several anamnestic criteria may be helpful to assess pre-test probability of COVID-19 in patients with common cold symptoms.


2019 ◽  
pp. 1-10 ◽  
Author(s):  
Stanley J. Weinberger ◽  
Kelly J. Cowan ◽  
Keith J. Robinson ◽  
Christine A. Pellegrino ◽  
Barbara L. Frankowski ◽  
...  

2011 ◽  
Vol 20 (12) ◽  
pp. 2210-2216 ◽  
Author(s):  
Michel Rossignol ◽  
Bernard Begaud ◽  
Bernard Avouac ◽  
France Lert ◽  
Frederic Rouillon ◽  
...  

1999 ◽  
Vol 89 (4) ◽  
pp. 199-211
Author(s):  
SD Chinn

This article describes a curriculum that could be included in podiatric residencies to help residents function successfully in a managed-care environment. Various groups have identified and implemented the competencies necessary to function within such an environment. Podiatric residents, who are well trained in the clinical management of podiatric problems, can succeed in a managed-care environment if residency programs include training objectives and methods to address these competencies. This article describes the managed-care components of two primary-care residency programs and a podiatric program and proposes a managed-care curriculum for podiatric residencies. The author's goal is to educate residency directors and faculty members on possible objectives and methods that can enhance the podiatric resident's educational experience and knowledge of managed care.


2008 ◽  
Vol 97 (1-2) ◽  
pp. 105-113 ◽  
Author(s):  
P ROUX ◽  
V VILLES ◽  
J BLANCHE ◽  
D BRY ◽  
B SPIRE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document